(Q35141918)

6 August 2017

1 reference

title

Short-term, high-dose pamidronate-induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicity (English)

1 reference

acute kidney tubular necrosis

6 August 2017

main subject

1 reference

Debasish Banerjee

1

1 reference

6 August 2017

Arif Asif

2

1 reference

6 August 2017

Liliane Striker

3

1 reference

6 August 2017

Richard A Preston

4

1 reference

6 August 2017

Jacques J Bourgoignie

5

1 reference

6 August 2017

David Roth

6

1 reference

6 August 2017

publication date

1 May 2003

1 reference

American Journal of Kidney Diseases

6 August 2017

published in

1 reference

6 August 2017

volume

41

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

E18

1 reference

Reversal of Left Ventricular Hypertrophy Following Recombinant Human Erythropoietin Treatment of Anaemic Dialysed Uraemic Patients

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Cardiac function and hematocrit level

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

The safety of intravenous iron dextran in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Intravenous Iron Dextran in Clinical Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Donation of Blood Is Associated with Reduced Risk of Myocardial Infarction: The Kuopio Ischaemic Heart Disease Risk Factor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Serum iron and risk of fatal acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Serum ferritin and ceruloplasmin as coronary risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Body iron stores, dietary iron intake and coronary heart disease mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Coronary heart disease and iron status: meta-analyses of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Blood donations and risk of coronary heart disease in men

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900373-1

7 January 2021

10.1016/S0272-6386(03)00373-1

Identifiers

DOI

1 reference

6 August 2017

1 reference